—A recent analysis showed that health concerns, rather than costs, influenced treatment strategies in commercially insured men with prostate cancer. Among men with newly diagnosed prostate cancer, ...
Thousands of men with prostate cancer will be offered a life-extending drug on the NHS within weeks. For the first time patients whose prostate cancer has not spread will be able to receive the drug ...
Cancer diagnoses are both more common and more survivable than ever. The question is whether you can afford life-saving ...
2d
Thousands more to get life-saving prostate cancer drug on NHS after The Sun exposed postcode lottery
THOUSANDS more men will get a life-saving prostate cancer drug on the NHS in a win for The Sun after we revealed the deadly ...
A new study compares outcomes among younger men with prostate cancer who are treated with intensity-modulated radiotherapy (IMRT), which is the most commonly used form of radiotherapy (RT) in the ...
New Publication Shows PROSTOX™ ultra Test Delivers Significant Health System Cost Savings and Quality-of-Life Gains for Prostate Cancer Patients Undergoing Radiation Therapy MiraDx, a molecular ...
A research team from the Department of Surgery and the Department of Medicine, School of Clinical Medicine, LKS Faculty of ...
A research team from the Department of Surgery and the Department of Medicine, School of Clinical Medicine, LKS Faculty of ...
Testing the molecular profile of prostate tumours identifies which patients with advanced prostate cancer are more likely to benefit from a chemotherapy treatment called docetaxel and live longer, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback